146 related articles for article (PubMed ID: 9099979)
1. Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas.
Würl P; Taubert H; Meye A; Dansranjavin T; Weber E; Günther D; Berger D; Schmidt H; Dralle H; Rath FW
Virchows Arch; 1997 Mar; 430(3):221-5. PubMed ID: 9099979
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of procathepsin L and cathepsin B in cutaneous Kaposi's sarcoma.
Thewes M; Engst R; Jürgens M; Borelli S
Int J Dermatol; 1997 Feb; 36(2):100-3. PubMed ID: 9109004
[TBL] [Abstract][Full Text] [Related]
3. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.
Lah TT; Kalman E; Najjar D; Gorodetsky E; Brennan P; Somers R; Daskal I
Hum Pathol; 2000 Feb; 31(2):149-60. PubMed ID: 10685628
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin protease expression in infiltrative soft tissue sarcomas: cathepsin-K correlates with infiltrative tumor growth and clinical outcomes.
Fujiwara T; Zhang L; Chandler A; Sung S; Yakoub M; Linkov I; Hameed M; Healey JH
Hum Pathol; 2023 Apr; 134():30-44. PubMed ID: 36565726
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors.
Kawasaki G; Kato Y; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Apr; 93(4):446-54. PubMed ID: 12029284
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomas.
Würl P; Meye A; Lautenschläger C; Schmidt H; Bache M; Kalthoff H; Schönfelder M; Rath FW; Taubert H
Cancer Lett; 1999 May; 139(2):159-65. PubMed ID: 10395173
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
[TBL] [Abstract][Full Text] [Related]
8. Molecular insight into propeptide-protein interactions in cathepsins L and O.
Reif MM; Mach L; Oostenbrink C
Biochemistry; 2012 Oct; 51(43):8636-53. PubMed ID: 23009386
[TBL] [Abstract][Full Text] [Related]
9. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
Salas S; Stoeckle E; Collin F; Bui B; Terrier P; Guillou L; Trassard M; Ranchere-Vince D; Gregoire F; Coindre JM
Eur J Cancer; 2009 Aug; 45(12):2091-102. PubMed ID: 19351580
[TBL] [Abstract][Full Text] [Related]
10. Augmented excretion of procathepsin L of a fos-transferred highly metastatic rat cell line.
Taniguchi S; Nishimura Y; Takahashi T; Baba T; Kato K
Biochem Biophys Res Commun; 1990 Apr; 168(2):520-6. PubMed ID: 2185753
[TBL] [Abstract][Full Text] [Related]
11. Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma.
Dohchin A; Suzuki JI; Seki H; Masutani M; Shiroto H; Kawakami Y
Cancer; 2000 Aug; 89(3):482-7. PubMed ID: 10931446
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer.
Thomssen C; Schmitt M; Goretzki L; Oppelt P; Pache L; Dettmar P; Jänicke F; Graeff H
Clin Cancer Res; 1995 Jul; 1(7):741-6. PubMed ID: 9816040
[TBL] [Abstract][Full Text] [Related]
13. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
[TBL] [Abstract][Full Text] [Related]
14. Expression of insulin-like growth factor mitogenic signals in adult soft-tissue sarcomas: significant correlation with malignant potential.
Busund LT; Ow KT; Russell P; Crowe PJ; Yang JL
Virchows Arch; 2004 Feb; 444(2):142-8. PubMed ID: 14673647
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of cathepsins B, D and L in the rat osteoclast.
Goto T; Tsukuba T; Kiyoshima T; Nishimura Y; Kato K; Yamamoto K; Tanaka T
Histochemistry; 1993 May; 99(5):411-4. PubMed ID: 8335484
[TBL] [Abstract][Full Text] [Related]
16. Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas.
Kersting C; Packeisen J; Leidinger B; Brandt B; von Wasielewski R; Winkelmann W; van Diest PJ; Gosheger G; Buerger H
J Clin Pathol; 2006 Jun; 59(6):585-90. PubMed ID: 16461571
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral gene delivery of anti-cathepsin L single-chain variable fragment by lentiviral vector inhibits tumor progression induced by human melanoma cells.
Frade R; Rousselet N; Jean D
Cancer Gene Ther; 2008 Sep; 15(9):591-604. PubMed ID: 18617916
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.
Cordes C; Bartling B; Simm A; Afar D; Lautenschläger C; Hansen G; Silber RE; Burdach S; Hofmann HS
Lung Cancer; 2009 Apr; 64(1):79-85. PubMed ID: 18760860
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.
Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J
Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984
[TBL] [Abstract][Full Text] [Related]
20. Evidence that aspartic proteinase is involved in the proteolytic processing event of procathepsin L in lysosomes.
Nishimura Y; Kawabata T; Furuno K; Kato K
Arch Biochem Biophys; 1989 Jun; 271(2):400-6. PubMed ID: 2658811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
